We describe a Tunisian family carrier of the same rare mutation in TARDBP but developing different neurodegenerative disease with heterogenous features. We explored the possible genetic modifiers leading to the observed intrafamilial phenotypic variability. Genetic analysis identified TARDBP p.G294A mutation among4 members. Additionally, the ALS case was muted in GBA. While the three cases of AD were carriers of PRKN and GBA mutations. Finally, the FTD-parkinsonism patient was mutated for LRRK2 p.G2019S that might increase his susceptibility to develop Parkinsonism spectrum. Genetic variants of TARDBP may influence the clinical manifestation in ALS case.

Expanding the phenotype of TARDBP mutation in a Tunisian family with clinical phenotype heterogeneity / I. Kacem, I. Sghaier, N. Ticozzi, S. Mrabet, S. Paverelli, A. Nasri, A. Ratti, M. Ben Djebara, A. Gargouri-Berrachid, V. Silani, R. Gouider. - In: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. - ISSN 2167-9223. - 23:7-8(2022 Oct 02), pp. 623-626. [10.1080/21678421.2022.2089856]

Expanding the phenotype of TARDBP mutation in a Tunisian family with clinical phenotype heterogeneity

N. Ticozzi;A. Ratti;V. Silani;
2022

Abstract

We describe a Tunisian family carrier of the same rare mutation in TARDBP but developing different neurodegenerative disease with heterogenous features. We explored the possible genetic modifiers leading to the observed intrafamilial phenotypic variability. Genetic analysis identified TARDBP p.G294A mutation among4 members. Additionally, the ALS case was muted in GBA. While the three cases of AD were carriers of PRKN and GBA mutations. Finally, the FTD-parkinsonism patient was mutated for LRRK2 p.G2019S that might increase his susceptibility to develop Parkinsonism spectrum. Genetic variants of TARDBP may influence the clinical manifestation in ALS case.
DNA; TARDBP; biomarker; genetics; heterogeneity; inbreeding; modulators; oligogenic profile;
Settore MED/26 - Neurologia
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
2-ott-2022
5-lug-2022
Article (author)
File in questo prodotto:
File Dimensione Formato  
Kacem I ALS_FTD 2022.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 980.18 kB
Formato Adobe PDF
980.18 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/933991
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact